relonchem limited
relonchem limited Company Information
Company Number
04773758
Website
www.relonchem.comRegistered Address
cheshire house gorsey lane, widnes, cheshire, WA8 0RP
Industry
Wholesale of pharmaceutical goods
Telephone
-
Next Accounts Due
December 2025
Group Structure
View All
Shareholders
marksans pharma uk ltd 100%
relonchem limited Estimated Valuation
Pomanda estimates the enterprise value of RELONCHEM LIMITED at £74.1m based on a Turnover of £46.5m and 1.59x industry multiple (adjusted for size and gross margin).
relonchem limited Estimated Valuation
Pomanda estimates the enterprise value of RELONCHEM LIMITED at £169.1m based on an EBITDA of £15.5m and a 10.92x industry multiple (adjusted for size and gross margin).
relonchem limited Estimated Valuation
Pomanda estimates the enterprise value of RELONCHEM LIMITED at £22.9m based on Net Assets of £49.9m and 0.46x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Relonchem Limited Overview
Relonchem Limited is a live company located in cheshire, WA8 0RP with a Companies House number of 04773758. It operates in the wholesale of pharmaceutical goods sector, SIC Code 46460. Founded in May 2003, it's largest shareholder is marksans pharma uk ltd with a 100% stake. Relonchem Limited is a mature, large sized company, Pomanda has estimated its turnover at £46.5m with high growth in recent years.
Upgrade for unlimited company reports & a free credit check
Relonchem Limited Health Check
Pomanda's financial health check has awarded Relonchem Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 7 measures and has 3 areas for improvement. Company Health Check FAQs
7 Strong
2 Regular
3 Weak
Size
annual sales of £46.5m, make it larger than the average company (£27.7m)
£46.5m - Relonchem Limited
£27.7m - Industry AVG
Growth
3 year (CAGR) sales growth of 22%, show it is growing at a faster rate (5.5%)
22% - Relonchem Limited
5.5% - Industry AVG
Production
with a gross margin of 38.3%, this company has a lower cost of product (24.3%)
38.3% - Relonchem Limited
24.3% - Industry AVG
Profitability
an operating margin of 32.7% make it more profitable than the average company (4.1%)
32.7% - Relonchem Limited
4.1% - Industry AVG
Employees
with 14 employees, this is below the industry average (42)
14 - Relonchem Limited
42 - Industry AVG
Pay Structure
on an average salary of £153.9k, the company has a higher pay structure (£69.9k)
£153.9k - Relonchem Limited
£69.9k - Industry AVG
Efficiency
resulting in sales per employee of £3.3m, this is more efficient (£799.8k)
£3.3m - Relonchem Limited
£799.8k - Industry AVG
Debtor Days
it gets paid by customers after 63 days, this is near the average (60 days)
63 days - Relonchem Limited
60 days - Industry AVG
Creditor Days
its suppliers are paid after 11 days, this is quicker than average (31 days)
11 days - Relonchem Limited
31 days - Industry AVG
Stock Days
it holds stock equivalent to 74 days, this is in line with average (64 days)
74 days - Relonchem Limited
64 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 161 weeks, this is more cash available to meet short term requirements (10 weeks)
161 weeks - Relonchem Limited
10 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 13.2%, this is a lower level of debt than the average (52.1%)
13.2% - Relonchem Limited
52.1% - Industry AVG
RELONCHEM LIMITED financials
Relonchem Limited's latest turnover from March 2024 is £46.5 million and the company has net assets of £49.9 million. According to their latest financial statements, Relonchem Limited has 14 employees and maintains cash reserves of £23.5 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 46,515,049 | 41,424,228 | 29,079,189 | 25,483,804 | 26,232,789 | 23,828,455 | 24,096,505 | 10,136,541 | 12,580,618 | 17,052,510 | 11,324,964 | 6,927,927 | 5,506,725 | 5,360,419 | 7,677,380 |
| Other Income Or Grants | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost Of Sales | 28,698,975 | 21,942,703 | 20,173,832 | 14,919,097 | 17,979,996 | 18,542,766 | 18,731,137 | 9,801,515 | 10,512,712 | 12,340,147 | 9,270,312 | 6,158,812 | 5,038,082 | 5,249,273 | 7,605,545 |
| Gross Profit | 17,816,074 | 19,481,525 | 8,905,357 | 10,564,707 | 8,252,793 | 5,285,689 | 5,365,368 | 335,026 | 2,067,906 | 4,712,363 | 2,054,652 | 769,115 | 468,643 | 111,146 | 71,835 |
| Admin Expenses | 2,625,697 | 2,537,999 | 2,023,241 | 2,312,012 | 2,196,506 | 1,557,565 | 1,367,032 | 1,044,247 | 1,221,636 | 827,139 | 703,571 | 626,101 | 680,244 | 698,777 | 1,228,179 |
| Operating Profit | 15,190,377 | 16,943,526 | 6,882,116 | 8,252,695 | 6,056,287 | 3,728,124 | 3,998,336 | -709,221 | 846,270 | 3,885,224 | 1,351,081 | 143,014 | -211,601 | -587,631 | -1,156,344 |
| Interest Payable | 0 | 0 | 2,801 | 20,205 | 9,541 | 14,876 | 70,868 | 72,471 | 32,913 | 74,983 | 77,384 | 84,924 | 75,548 | 50,350 | 20,666 |
| Interest Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2,616 | 102 | 6,612 |
| Pre-Tax Profit | 15,190,377 | 16,943,526 | 6,879,315 | 8,232,490 | 6,046,746 | 3,713,248 | 3,927,468 | -781,692 | 813,357 | 3,810,241 | 1,273,697 | 58,090 | -284,533 | -637,879 | -1,170,398 |
| Tax | -3,705,580 | -3,250,691 | -1,300,610 | -1,626,981 | -1,173,608 | -697,418 | -784,143 | 86,847 | -202,061 | -840,469 | -149,351 | 0 | 8,774 | -2,366 | 60,260 |
| Profit After Tax | 11,484,797 | 13,692,835 | 5,578,705 | 6,605,509 | 4,873,138 | 3,015,830 | 3,143,325 | -694,845 | 611,296 | 2,969,772 | 1,124,346 | 58,090 | -275,759 | -640,245 | -1,110,138 |
| Dividends Paid | 1,250,000 | 1,250,000 | 600,000 | 500,000 | 2,000,000 | 0 | 0 | 0 | 0 | 2,500,000 | 0 | 0 | 0 | 0 | 0 |
| Retained Profit | 10,234,797 | 12,442,835 | 4,978,705 | 6,105,509 | 2,873,138 | 3,015,830 | 3,143,325 | -694,845 | 611,296 | 469,772 | 1,124,346 | 58,090 | -275,759 | -640,245 | -1,110,138 |
| Employee Costs | 2,155,082 | 1,303,614 | 1,136,041 | 1,200,023 | 1,248,733 | 798,775 | 788,766 | 396,463 | 370,490 | 291,980 | 223,046 | 151,647 | 120,071 | 92,972 | 353,467 |
| Number Of Employees | 14 | 13 | 14 | 15 | 16 | 12 | 9 | 8 | 7 | 7 | 5 | 4 | 4 | 3 | 10 |
| EBITDA* | 15,494,218 | 17,282,791 | 7,191,710 | 8,521,546 | 6,414,596 | 4,058,884 | 4,260,232 | -462,873 | 1,092,354 | 4,131,050 | 1,592,863 | 377,214 | 22,107 | -353,923 | -920,295 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 52,193 | 90,222 | 166,759 | 217,147 | 162,791 | 134,481 | 6,298 | 6,793 | 8,476 | 9,925 | 8,462 | 11,283 | 12,483 | 12,110 | 10,623 |
| Intangible Assets | 2,544,009 | 2,668,367 | 3,065,469 | 3,326,149 | 3,867,111 | 3,182,142 | 2,758,120 | 2,717,928 | 2,961,273 | 3,204,618 | 3,360,289 | 3,470,200 | 3,703,200 | 3,935,708 | 4,168,216 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 2,596,202 | 2,758,589 | 3,232,228 | 3,543,296 | 4,029,902 | 3,316,623 | 2,764,418 | 2,724,721 | 2,969,749 | 3,214,543 | 3,368,751 | 3,481,483 | 3,715,683 | 3,947,818 | 4,178,839 |
| Stock & work in progress | 5,851,213 | 5,886,456 | 5,714,092 | 5,084,520 | 3,327,953 | 5,387,609 | 6,118,820 | 4,944,755 | 4,372,866 | 4,396,277 | 1,482,379 | 305,146 | 895,397 | 512,048 | 570,074 |
| Trade Debtors | 8,075,200 | 8,807,926 | 6,440,979 | 5,862,459 | 5,304,698 | 4,387,233 | 3,351,381 | 1,932,686 | 2,343,458 | 2,541,431 | 2,819,773 | 1,396,989 | 1,145,121 | 917,100 | 1,738,817 |
| Group Debtors | 16,848,910 | 14,427,656 | 9,538,091 | 6,951,886 | 5,709,896 | 6,696,089 | 6,178,474 | 5,196,320 | 2,332,961 | 2,483,440 | 3,144,695 | 2,858,659 | 2,974,461 | 0 | 0 |
| Misc Debtors | 571,354 | 298,984 | 171,026 | 150,618 | 133,031 | 239,858 | 66,070 | 354,588 | 62,060 | 111,206 | 15,165 | 11,955 | 111,422 | 71,085 | 168,042 |
| Cash | 23,532,315 | 12,783,332 | 7,170,448 | 5,128,684 | 4,839,745 | 1,243,770 | 1,294,297 | 475,359 | 372,576 | 716,790 | 257,931 | 173,931 | 82,637 | 40,007 | 152,099 |
| misc current assets | 0 | 4,000,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 54,878,992 | 46,204,354 | 29,034,636 | 23,178,167 | 19,315,323 | 17,954,559 | 17,009,042 | 12,903,708 | 9,483,921 | 10,249,144 | 7,719,943 | 4,746,680 | 5,209,038 | 1,540,240 | 2,629,032 |
| total assets | 57,475,194 | 48,962,943 | 32,266,864 | 26,721,463 | 23,345,225 | 21,271,182 | 19,773,460 | 15,628,429 | 12,453,670 | 13,463,687 | 11,088,694 | 8,228,163 | 8,924,721 | 5,488,058 | 6,807,871 |
| Bank overdraft | 0 | 0 | 0 | 99,355 | 182,600 | 181,622 | 692,775 | 1,391,104 | 1,390,480 | 1,057,661 | 1,522,049 | 1,501,529 | 1,513,977 | 1,099,535 | 519,443 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 916,047 | 1,146,713 | 1,459,583 | 616,472 | 729,671 | 602,298 | 618,797 | 636,475 | 845,298 | 755,700 | 580,643 | 323,416 | 235,622 | 123,158 | 521,977 |
| Group/Directors Accounts | 2,481,409 | 1,575,008 | 0 | 0 | 1,433,218 | 5,928,545 | 7,128,475 | 6,437,791 | 2,086,159 | 3,522,799 | 1,937,065 | 752,740 | 1,609,653 | 998,748 | 944,563 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 4,182,989 | 6,581,270 | 3,590,164 | 3,767,224 | 4,866,833 | 1,298,952 | 1,089,478 | 62,449 | 336,278 | 943,368 | 334,549 | 60,436 | 33,517 | 58,906 | 564,817 |
| total current liabilities | 7,580,445 | 9,302,991 | 5,049,747 | 4,483,051 | 7,212,322 | 8,011,417 | 9,529,525 | 8,527,819 | 4,658,215 | 6,279,528 | 4,374,306 | 2,638,121 | 3,392,769 | 2,280,347 | 2,550,800 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 409,115 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 409,115 |
| total liabilities | 7,580,445 | 9,302,991 | 5,049,747 | 4,483,051 | 7,212,322 | 8,011,417 | 9,529,525 | 8,527,819 | 4,658,215 | 6,279,528 | 4,374,306 | 2,638,121 | 3,392,769 | 2,280,347 | 2,959,915 |
| net assets | 49,894,749 | 39,659,952 | 27,217,117 | 22,238,412 | 16,132,903 | 13,259,765 | 10,243,935 | 7,100,610 | 7,795,455 | 7,184,159 | 6,714,388 | 5,590,042 | 5,531,952 | 3,207,711 | 3,847,956 |
| total shareholders funds | 49,894,749 | 39,659,952 | 27,217,117 | 22,238,412 | 16,132,903 | 13,259,765 | 10,243,935 | 7,100,610 | 7,795,455 | 7,184,159 | 6,714,388 | 5,590,042 | 5,531,952 | 3,207,711 | 3,847,956 |
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | 15,190,377 | 16,943,526 | 6,882,116 | 8,252,695 | 6,056,287 | 3,728,124 | 3,998,336 | -709,221 | 846,270 | 3,885,224 | 1,351,081 | 143,014 | -211,601 | -587,631 | -1,156,344 |
| Depreciation | 38,029 | 76,537 | 79,425 | 56,682 | 50,862 | 36,583 | 3,630 | 3,003 | 2,739 | 2,481 | 2,821 | 1,200 | 1,200 | 1,200 | 3,541 |
| Amortisation | 265,812 | 262,728 | 230,169 | 212,169 | 307,447 | 294,177 | 258,266 | 243,345 | 243,345 | 243,345 | 238,961 | 233,000 | 232,508 | 232,508 | 232,508 |
| Tax | -3,705,580 | -3,250,691 | -1,300,610 | -1,626,981 | -1,173,608 | -697,418 | -784,143 | 86,847 | -202,061 | -840,469 | -149,351 | 0 | 8,774 | -2,366 | 60,260 |
| Stock | -35,243 | 172,364 | 629,572 | 1,756,567 | -2,059,656 | -731,211 | 1,174,065 | 571,889 | -23,411 | 2,913,898 | 1,177,233 | -590,251 | 383,349 | -58,026 | 570,074 |
| Debtors | 1,960,898 | 7,384,470 | 3,185,133 | 1,817,338 | -175,555 | 1,727,255 | 2,112,331 | 2,745,115 | -397,598 | -843,556 | 1,712,030 | 36,599 | 3,242,819 | -918,674 | 1,906,859 |
| Creditors | -230,666 | -312,870 | 843,111 | -113,199 | 127,373 | -16,499 | -17,678 | -208,823 | 89,598 | 175,057 | 257,227 | 87,794 | 112,464 | -398,819 | 521,977 |
| Accruals and Deferred Income | -2,398,281 | 2,991,106 | -177,060 | -1,099,609 | 3,567,881 | 209,474 | 1,027,029 | -273,829 | -607,090 | 608,819 | 274,113 | 26,919 | -25,389 | -505,911 | 564,817 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | 7,234,036 | 9,153,502 | 2,742,446 | 2,107,852 | 11,171,453 | 2,558,397 | 1,199,044 | -4,175,682 | 793,810 | 2,004,115 | -914,411 | 1,045,579 | -3,508,212 | -284,319 | -2,250,174 |
| Investing Activities | |||||||||||||||
| capital expenditure | -1,320 | -1,290 | -100,080 | ||||||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | -1,320 | -1,290 | -100,080 | ||||||||||||
| Financing Activities | |||||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 906,401 | 1,575,008 | 0 | -1,433,218 | -4,495,327 | -1,199,930 | 690,684 | 4,351,632 | -1,436,640 | 1,585,734 | 1,184,325 | -856,913 | 610,905 | 54,185 | 944,563 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -409,115 | 409,115 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | |||||||||||||||
| interest | 0 | 0 | -2,801 | -20,205 | -9,541 | -14,876 | -70,868 | -72,471 | -32,913 | -74,983 | -77,384 | -84,924 | -72,932 | -50,248 | -14,054 |
| cash flow from financing | 906,401 | 1,575,008 | -2,801 | -1,453,423 | -4,504,868 | -1,214,806 | 619,816 | 4,279,161 | -1,469,553 | 1,510,750 | 1,106,941 | -941,837 | 3,137,973 | -405,178 | 6,297,718 |
| cash and cash equivalents | |||||||||||||||
| cash | 10,748,983 | 5,612,884 | 2,041,764 | 288,939 | 3,595,975 | -50,527 | 818,938 | 102,783 | -344,214 | 458,859 | 84,000 | 91,294 | 42,630 | -112,092 | 152,099 |
| overdraft | 0 | 0 | -99,355 | -83,245 | 978 | -511,153 | -698,329 | 624 | 332,819 | -464,388 | 20,520 | -12,448 | 414,442 | 580,092 | 519,443 |
| change in cash | 10,748,983 | 5,612,884 | 2,141,119 | 372,184 | 3,594,997 | 460,626 | 1,517,267 | 102,159 | -677,033 | 923,247 | 63,480 | 103,742 | -371,812 | -692,184 | -367,344 |
relonchem limited Credit Report and Business Information
Relonchem Limited Competitor Analysis
Perform a competitor analysis for relonchem limited by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other large companies, companies in WA8 area or any other competitors across 12 key performance metrics.
relonchem limited Ownership
RELONCHEM LIMITED group structure
Relonchem Limited has no subsidiary companies.
Ultimate parent company
MARKSANS PHARMA LTD
#0061417
2 parents
RELONCHEM LIMITED
04773758
relonchem limited directors
Relonchem Limited currently has 6 directors. The longest serving directors include Mr Mark Saldanha (Aug 2008) and Mr Jitendra Sharma (Aug 2008).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Mark Saldanha | India | 52 years | Aug 2008 | - | Director |
| Mr Jitendra Sharma | 55 years | Aug 2008 | - | Director | |
| Ms Sandra Saldanha | India | 52 years | Mar 2017 | - | Director |
| Mr Sathish Konasagar Jayanna | England | 51 years | Mar 2017 | - | Director |
| Mr Seetharama Buddharaju | England | 72 years | May 2020 | - | Director |
| Mr John Molyneux | 47 years | May 2024 | - | Director |
P&L
March 2024turnover
46.5m
+12%
operating profit
15.2m
-10%
gross margin
38.4%
-18.56%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
49.9m
+0.26%
total assets
57.5m
+0.17%
cash
23.5m
+0.84%
net assets
Total assets minus all liabilities
relonchem limited company details
company number
04773758
Type
Private limited with Share Capital
industry
46460 - Wholesale of pharmaceutical goods
incorporation date
May 2003
age
21
incorporated
UK
accounts
Full Accounts
ultimate parent company
previous names
N/A
last accounts submitted
March 2024
address
cheshire house gorsey lane, widnes, cheshire, WA8 0RP
accountant
-
auditor
PBG ASSOCIATES LIMITED
relonchem limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 2 charges/mortgages relating to relonchem limited. Currently there are 0 open charges and 2 have been satisfied in the past.
relonchem limited Companies House Filings - See Documents
| date | description | view/download |
|---|
